Laminin-5 (laminin-332), a key component of the basement membrane, is a heterotrimeric glycoprotein composed of α3. β3. and γ2 chains. The α3 subunit, encoded by the *LAMA3* gene, plays a critical role in epithelial-stromal adhesion, cell differentiation, and signaling. Laminin-5α3 antibodies specifically target the α3 chain, which is essential for anchoring epithelial cells to the underlying extracellular matrix. These antibodies are widely used in research to study tissue integrity, wound healing, and diseases linked to basement membrane dysfunction, such as epidermolysis bullosa and certain cancers.
In clinical diagnostics, laminin-5α3 antibodies help identify pathological conditions like mucous membrane pemphigoid and junctional epidermolysis bullosa (JEB), where genetic mutations in *LAMA3* disrupt laminin-332 assembly, leading to fragile skin and mucosal blistering. Additionally, altered laminin-5α3 expression is associated with tumor progression, as its cleavage by proteases like MMP-2/9 facilitates cancer cell invasion and metastasis.
Antibodies against laminin-5α3 are employed in techniques like immunohistochemistry, immunofluorescence, and Western blotting to visualize protein distribution, assess tissue pathology, and validate disease models. Their specificity makes them valuable tools for both mechanistic studies and therapeutic target exploration in epithelial biology and oncology.